Catherine K. Xu

Max Planck Institute for the Science of Light — Germany

Medicine · Health Sciences

24h-index2.1kcitations72works11.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(23), Parkinson's Disease Mechanisms and Treatments(11), SARS-CoV-2 and COVID-19 Research(9), Microfluidic and Capillary Electrophoresis Applications(7), Microfluidic and Bio-sensing Technologies(7)

Publications69 total

Neurodegeneration emerges at a cellular tipping point between aggregate accumulation and removal
2025· 3 citedOpen Access
Direct, high-throughput linking of single-cell imaging and gene expression
2025Open Access
Unraveling the regulatory dynamics of bidirectional promoters for modulating gene co-expression and metabolic flux in <i>Saccharomyces cerevisiae</i>
Nucleic Acids Research·2025· 4 citedOpen Access
α-Synuclein oligomers form by secondary nucleation
Nature Communications·2024· 43 citedOpen Access
α-Synuclein Oligomers Displace Monomeric α-Synuclein from Lipid Membranes
ACS Nano·2024· 12 citedOpen Access
Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells
Nature Communications·2024· 25 citedOpen Access
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy
Frontiers in Immunology·2024· 1 citedOpen Access
Co-expression of prepulse inhibition and Schizophrenia genes in the mouse and human brain
Neuroscience Applied·2024· 6 citedOpen Access
Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells
2023· 1 citedOpen Access
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD-20 therapy
2023· 1 citedOpen Access
α-Synuclein oligomers form by secondary nucleation
2023· 9 citedOpen Access
α-synuclein oligomers displace monomeric α-synuclein from lipid membranes
2023· 4 citedOpen Access
Microfluidic antibody affinity profiling of alloantibody-HLA interactions in human serum
Biosensors and Bioelectronics·2023· 20 citedOpen Access
Single-Molecule Sizing through Nanocavity Confinement
Nano Letters·2023· 9 citedOpen Access
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
iScience·2023· 12 citedOpen Access
Image-based cell sorting using focused travelling surface acoustic waves
Lab on a Chip·2023· 51 citedOpen Access
Ancestry-specific high-risk gene variant profiling unmasks diabetes-associated genes
Human Molecular Genetics·2022· 2 citedOpen Access
Effects of N-terminal Acetylation on the Aggregation of Disease-related α-synuclein Variants
Journal of Molecular Biology·2022· 33 citedOpen Access
Uncovering the universality of self-replication in protein aggregation and its link to disease
Science Advances·2022· 58 citedOpen Access
N-Terminal Acetylation of α-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates
Biochemistry·2022· 49 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Tuomas P. J. Knowles(34), Georg Meisl(22), Christopher M. Dobson(16), Michele Vendruscolo(13), Janet R. Kumita(13), Matthias M. Schneider(11), Georg Krainer(10), Vasilis Kosmoliaptsis(10), Raphaël P. B. Jacquat(9), Sara Linse(8), Sean R. A. Devenish(8), Marta Castellana-Cruz(8), Adriano Aguzzi(7), Sebastian Fiedler(7), Heike Fiegler(7), Michele Perni(6), Benedetta Mannini(6), David Klenerman(6), William E. Arter(6), Marc Emmenegger(6)